MMCAP International’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-325,000
Closed -$18.2K 217
2023
Q3
$18.2K Hold
325,000
0.01% 111
2023
Q2
$47.9K Hold
325,000
0.02% 78
2023
Q1
$30.9K Hold
325,000
0.01% 161
2022
Q4
$32.5K Hold
325,000
﹤0.01% 241
2022
Q3
$26K Hold
325,000
﹤0.01% 352
2022
Q2
$45K Hold
325,000
﹤0.01% 335
2022
Q1
$75K Buy
+325,000
New +$84.4K ﹤0.01% 402

MMCAP International's BIOSW Position: Q4 2023 in Review

MMCAP International sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 325,000 shares — an estimated $18.2K sold.

MMCAP International first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $75K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • MMCAP International reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • MMCAP International sold 325,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $18.2K.
  • MMCAP International first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
  • MMCAP International's BioPlus Acquisition Corp. Warrants position peaked at $75K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on MMCAP International's 13F filing for Q4 2023, filed 12 Feb 2024.